home / stock / bfriw / bfriw quote
Last: | $0.06 |
---|---|
Change Percent: | 0.0% |
Open: | $0.0595 |
Close: | $0.06 |
High: | $0.06 |
Low: | $0.0595 |
Volume: | 17,010 |
Last Trade Date Time: | 05/03/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.06 | $0.0595 | $0.06 | $0.06 | $0.0595 | 17,010 | 05-03-2024 |
$0.06 | $0.059899 | $0.06 | $0.06 | $0.059899 | 5,000 | 04-29-2024 |
$0.06 | $0.06 | $0.06 | $0.06 | $0.06 | 400 | 04-26-2024 |
$0.06 | $0.0595 | $0.06 | $0.06 | $0.055 | 16,439 | 04-25-2024 |
$0.055 | $0.055 | $0.055 | $0.055 | $0.055 | 2,435 | 04-24-2024 |
$0.0499 | $0 | $0.0499 | $0 | $0 | 100 | 04-23-2024 |
$0.0499 | $0.035 | $0.0499 | $0.055 | $0.035 | 4,546 | 04-22-2024 |
$0.035 | $0.035 | $0.035 | $0.035 | $0.034899 | 53,668 | 04-18-2024 |
$0.059 | $0.0587 | $0.059 | $0.059 | $0.0587 | 3,309 | 04-17-2024 |
$0.0454 | $0 | $0.0454 | $0 | $0 | 49 | 04-15-2024 |
$0.0454 | $0.0537 | $0.0454 | $0.0537 | $0.0454 | 980 | 04-12-2024 |
$0.0595 | $0.0595 | $0.0595 | $0.0595 | $0.0595 | 404 | 04-10-2024 |
$0.0351 | $0.035 | $0.0351 | $0.0367 | $0.035 | 10,745 | 04-09-2024 |
$0.0469 | $0.0469 | $0.0469 | $0.0469 | $0.0469 | 654 | 04-08-2024 |
$0.05 | $0.048139 | $0.05 | $0.05 | $0.048139 | 1,346 | 04-05-2024 |
$0.0366 | $0.050101 | $0.0366 | $0.050101 | $0.0366 | 2,100 | 04-03-2024 |
$0.05 | $0.05 | $0.05 | $0.05 | $0.05 | 1,039 | 04-02-2024 |
$0.0652 | $0.04 | $0.0652 | $0.07 | $0.0365 | 28,209 | 04-01-2024 |
$0.0676 | $0.0676 | $0.0676 | $0.0676 | $0.0676 | 1,197 | 03-29-2024 |
$0.0676 | $0.0676 | $0.0676 | $0.0676 | $0.0676 | 1,197 | 03-28-2024 |
News, Short Squeeze, Breakout and More Instantly...
Biofrontera Inc. Warrants Company Name:
BFRIW Stock Symbol:
NASDAQ Market:
WOBURN, Mass., Nov. 30, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, announced today that the Company will be participating in Benchmark’s 11th Annual Discovery One-on-One I...
Woburn, Nov. 28, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. ("Biofrontera" or the "Company") (NASDAQ: BFRI), announced today that they will be participating in Renmark Financial Communications Inc.’s live Virtual Non-Deal Roadshow Series to discuss its latest investor presentation on ...
WOBURN, Mass., Nov. 21, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, announced today the launch of a randomized, double-blind, vehicle-controlled, multicenter Phase 3 clini...